Calcifications at Digital Breast Tomosynthesis: Imaging Features and Biopsy Techniques

Abstract

Full-field digital mammography (FFDM), the standard of care for breast cancer screening, has some limitations. With the advent of digital breast tomosynthesis (DBT), improvements including decreased recall rates and increased cancer detection rates have been observed. The quasi-three-dimensional capability of DBT reduces breast tissue overlap, a significant limitation of FFDM. However, early studies demonstrate that a few cancers detected at FFDM may not be diagnosed at DBT-only screening, and lesions with calcifications as the dominant feature may look less suspicious at DBT or not be visible at all. These findings support the use of combined FFDM and DBT protocols to optimize screening performance. However, this combination would approximately double the patient's radiation exposure. The development of computer algorithms that generate two-dimensional synthesized mammography (SM) views from DBT has improved calcification conspicuity and sensitivity. Therefore, SM may substitute for FFDM in screening protocols, reducing radiation exposure. DBT plus SM demonstrates significantly better performance than that of FFDM alone, although there are reports of missed malignant calcifications. Thus, some centers continue to perform FFDM with DBT. Use of DBT in breast imaging has also necessitated the development of DBT-guided biopsy. DBT-guided biopsy may have a higher success rate than that of stereotactic biopsy, with a shorter procedure time. While DBT brings substantial improvements to breast cancer imaging, it is important to be aware of its strengths and limitations regarding detection of calcifications. This article reviews the imaging appearance of breast calcifications at DBT, discusses calcification biopsy techniques, and provides an overview of the current literature.

Breast cancer histopathological image classification using convolutional neural networks with small SE-ResNet module

“…Breast cancer develops from breast tissue identified by lump in the breast and there are some changes in normal conditions [5]. Clinical screening includes mammography [6], breast ultrasound [7], biopsy [8] and other method. A biopsy [8] is the only diagnostic procedure that can definitely determine if the suspicious area is cancerous.…”

“…Clinical screening includes mammography [6], breast ultrasound [7], biopsy [8] and other method. A biopsy [8] is the only diagnostic procedure that can definitely determine if the suspicious area is cancerous. The pathologists diagnose by visual inspection of histological slides under the microscope, which is considered as confirmatory gold standard for diagnosis [9].…”

Diabetes, Obesity, and Inflammation: Impact on Clinical and Radiographic Features of Breast Cancer

“…Any or all of these findings can be seen in a single mammogram and can create a convoluted picture for radiologists. (Adapted from [ 65 ]).…”

Tomosynthesis guided core biopsy of breast lesions – method review and our results

“…Neki autori navode pro blem biopsije finih kalcifikata, koji mogu biti teško vidljivi na slojevnoj snimci, što može dovesti do potre be konverzije u stereotaksijski postupak. 34,52 Drugi opi suju jednak klinički učinak obiju metoda u biopsiji mikrokalcifikata. 35 Mi smo sve promjene u postupku biopsije identificirali tomosintezom, bez uporabe 2D mamografije, premda uređaj ima mogućnost obaju na čina rada.…”